Cargando…

Advances in HER2-Positive Breast Cancer: Novel Therapies and Adverse Event Management

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Harborside Press LLC 2019
Materias:	CE Information
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522660/ https://www.ncbi.nlm.nih.gov/pubmed/33014513

Ejemplares similares

Advances in Oral Oncolytic Agents for Breast Cancer and Recommendations for Promoting Adherence
Publicado: (2020)

The Role of Advanced Practitioners in Optimizing Clinical Management and Support of Patients With Cytokine Release Syndrome From CAR T-Cell Therapy
Publicado: (2019)

Optimizing Treatment and Improving Outcomes for Patients With Acute Myeloid Leukemia: A Guide for Advanced Practitioners
Publicado: (2019)

Advances in HER2-Positive Breast Cancer: Novel Therapies and Adverse Event Management
por: Mahtani, Reshma, et al.
Publicado: (2019)

Atrial Fibrillation and Managed Care: Current Approaches and Future Directions for Long-Term Therapy
por: Sanoski, Cynthia A., et al.
Publicado: (2009)

Patient Perspective, Complexities, and Challenges in Managed Care
por: Jan, Saira
Publicado: (2010)

Body mass index (BMI) influence on Cetuximab-induced antibody-dependent cellular cytotoxicity in advanced colon cancer
por: Tralongo, Antonino Carmelo, et al.
Publicado: (2022)

Use of ß-blocker therapy to prevent primary bleeding of esophageal varices
por: Tursi, Tammy
Publicado: (2010)

Deceased Organ Donor Management and Organ Distribution From Organ Procurement Organization-Based Recovery Facilities Versus Acute-Care Hospitals
por: Vail, Emily A., et al.
Publicado: (2023)

Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment
por: Pardo-Cabello, Alfredo Jose, et al.
Publicado: (2021)

Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions-reply
por: Crescioli, Giada, et al.
Publicado: (2021)

Eating disorder symptomatology and substance use disorders: Prevalence and shared risk in a population based twin sample
por: Baker, Jessica H, et al.
Publicado: (2010)

Mediterranean Diet and Prevention of Chronic Diseases
por: Romagnolo, Donato F., et al.
Publicado: (2017)

What Is the Evidence Base for a Potassium Requirement?
por: Weaver, Connie M., et al.
Publicado: (2018)

Choline: The Underconsumed and Underappreciated Essential Nutrient
por: Wallace, Taylor C., et al.
Publicado: (2018)

Pulmonary embolism and screening for concomitant proximal deep vein thrombosis in noncritically ill hospitalized patients with coronavirus disease 2019
por: Lazzeri, Chiara, et al.
Publicado: (2020)

Derivation of age-adjusted LACE index thresholds in the prediction of mortality and frequent hospital readmissions in adults
por: Fry, Christopher Henry, et al.
Publicado: (2020)

COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine
por: Polosa, Riccardo, et al.
Publicado: (2020)

High-dose steroids for the treatment of severe COVID-19: a new therapeutic tool?
por: Cameli, Paolo, et al.
Publicado: (2021)

Organ Transplantation Outcomes of Deceased Organ Donors in Organ Procurement Organization-Based Recovery Facilities Versus Acute-Care Hospitals
por: Vail, Emily A., et al.
Publicado: (2023)

New Agents for the Management of Advanced HER2-Positive Breast Cancer
por: Royce, Melanie, et al.
Publicado: (2016)

Early Adverse Events predict Survival Outcomes in HER2-positive Advanced Breast Cancer Patients treated with Lapatinib plus Capecitabine
por: Ang, Fang L.I., et al.
Publicado: (2020)

Patient-reported outcomes predict survival and adverse events following anticancer treatment initiation in advanced HER2-positive breast cancer
por: Modi, N.D., et al.
Publicado: (2022)

Novel Therapies for the Treatment of HER2-Positive Advanced Breast Cancer: A Canadian Perspective
por: Ferrario, Cristiano, et al.
Publicado: (2022)

Switching positions: Assessing the dynamics of conjugational heterogeneity in antibody–drug conjugates using CE‐SDS
por: van den Berg, Eline B. A., et al.
Publicado: (2022)

Camostat mesilate therapy for COVID-19
por: Uno, Yoshiharu
Publicado: (2020)

The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies: comment
por: De Cauwer, Harald
Publicado: (2020)

The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based antihypertensive therapies—reply
por: Albini, Adriana, et al.
Publicado: (2020)

Managing anticoagulation in the COVID-19 era between lockdown and reopening phases: Comment
por: Magon, Arianna, et al.
Publicado: (2021)

Recent advances in systemic therapy: Advances in systemic therapy for HER2-positive metastatic breast cancer
por: Morrow, Phuong Khanh H, et al.
Publicado: (2009)

Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer
por: Stanowicka-Grada, Malwina, et al.
Publicado: (2023)

Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment
por: Bandera, Alessandra, et al.
Publicado: (2021)

A fatal unsuspected case of acquired A hemophilia. Misleading role of therapy with acetylsalicylic acid?
por: Puccetti, Luca, et al.
Publicado: (2021)

Advances in neoadjuvant therapy for HER2-positive breast cancers: a narrative review
por: Wang, Qianmu, et al.
Publicado: (2022)

Targeted therapy for HER2 positive breast cancer
por: Incorvati, Jason A, et al.
Publicado: (2013)

Lapatinib in combination with capecitabine in the management of ErbB2-positive (HER2-positive) advanced breast cancer
por: Kaufman, Bella, et al.
Publicado: (2008)

SARS-CoV-2 vs smallpox: mass vaccinations in the mirror
por: Bianucci, Raffaella, et al.
Publicado: (2021)

Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment
por: Allione, Attilio, et al.
Publicado: (2020)

Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment
por: Roncon, Loris, et al.
Publicado: (2020)

Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine
por: Carli, Giuseppe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rflimp5ocneulmpjq0upo97amk